Neo-adjuvant chemotherapy in breast cancers larger than 3 cm. Ten-year results from a randomised trial;Résultats à 10 ans d'un essai randomisé de chimiothérapie néo-adjuvante dans les cancers du sein de plus de 3 cm

Chirurgie

Volumn 123, Issue 3, 1998, Pages 247-256

  Avril, A ^a   Faucher, A ^a   Bussieres E ^a   Stockle E ^a   Durand, M ^a   Mauriac, L ^a   Bonichon, F ^a   Dilhuydy, J M ^a   Campo, M L ^a  

^a INSTITUT BERGONIÉ   (France)

Author keywords

Neo adjuvant chemotherapy; Operable breast cancer; Randomised trial

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ALGORITHM; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CONSERVATIVE TREATMENT; LYMPH NODE DISSECTION; MASTECTOMY; METASTASIS; TREATMENT OUTCOME; ADJUVANT THERAPY; AGED; BREAST TUMOR; CANCER STAGING; CLINICAL TRIAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY, SIMPLE; NEOADJUVANT THERAPY; NEOPLASM STAGING; SURVIVAL RATE;

EID: 0032087355     PISSN: 00014001     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4001(98)80116-5     Document Type: Article

References (28)

1. Gazet JC, Coombes RC, Ford HT, Griffin M, Corbishley C, Makinde V et al. Assessment of the effect of pretreatment with neo-adjuvant therapy on primary breast cancer. Br J Cancer 1996 ; 73 : 758-62
2. Darai E, Mosseri V, Hamelin JP et al. Chirurgie conservatrice après radiothérapie à dose préopératoire dans le traitement des cancers du sein. Press Méd 1991 ; 20 : 2144-8
3. Durand JC, Solalinde V, Mathieu J et al. La chirurgie conservatrice après radiothérapie à doses préopératoires dans le traitement des cancers du sein. Bull Cancer 1987 ; 74 : 641-6
4. Auclerc G, Borel C, Khayat D, Soubrane C, Weil M. Primary chemotherapy in the treatment of breast cancer. Ann Chir Plast Esthet 1992 ; 37 : 663-9
5. Semiglazov VF, Topuzov EE, Bavli JL, Moiseyenko VM, Ivanova OA et al. Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer. Ann Oncol 1994 ; 5 : 591-5
6. Cocconi G, di Blasio B, Bisagni G, Alberti GG, Botti E, Anghinoni E. Neoadjuvant chemotherapy or chemotherapy and endocrine therapy in locally advanced breast carcinoma. A prospective randomized study. Am J Clin Oncol 1990 ; 13 : 226-32
7. Powles TJ, Hickish TF, Makris A, Ashley SE, O'Brien MER, Tidy VA et al. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J Clin Oncol 1995 ; 13 : 547-52
8. Scholl SM, Fourquet A, Asselain B, Pierga JY, Vilcoq JR, Durand JC et al. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of an randomised trial : S6. Eur J Cancer 1994 ; 30A : 645-52
9. Fisher B, Brown A, Mamounas E, Wieand S, Robidoux A, Margolese G et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 1997 ; 15 : 2483-93
10. Bonadonna G, Valagussa P, Brambilla C, Moliterni A, Zambetti M, Ferrari L. Adjuvant and neoadjuvant treatment of breast cancer with chemotherapy and/or endocrine therapy. Semin Oncol 1991 ; 18 : 515-24
11. Veronesi U, Bonadonna G, Zurrida S, Galimberti V, Greco M, Brambilla C et al. Conservation surgery after primary chemotherapy in large carcinomas of the breast. Ann Surg 1995 ; 222 : 612-8
12. Ferrero JM, Namer M, Dufour JF, Largillier R, Creisson A, Teissier E et al. Étude comparative de quatre protocoles successifs de chimiothérapie première dans le cancer du sein localement avancé. Bull Cancer 1997 ; 84 : 10-6
13. Gradishar WJ. Docetaxel as neoadjuvant chemotherapy in patients with stage III breast cancer. Oncology 1997 ; 11 : 15-8
14. Gupta P, Bijlani L, Rath GK, Misra A, Mishra MC, Shukla NK et al. Neoadjuvant chemotherapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) or cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in 69 cases of locally advances (stage IIIb) breast cancer. Jpn J Surg 1991 ; 21 : 637-42
15. Lemaire M, Focan C, Desaive C, Closon-Dejardin MT, Duvivier J, Friedman V et al. Neoadjuvant chemotherapy, with mitoxantrone, cyclophosphamide and fluorouracil in operable breast cancer of intermediate stage: first results of a phase II study in 40 patients. Bull Cancer 1992 ; 79 : 883-91
16. Mumtaz H, Davidson T, Spittle M, Tobias J, Hall-Craggs MA, Cowley G et al. Breast surgery after neoadjuvant treatment. Is it necessary? Eur J Surg Oncol 1996 ; 22 : 335-41
17. Cure H, Charrier S, Fernere JP, Van Praagh I, Assier I, Feillel V et al. First-line chemotherapy in operable breast neoplasms: results of 3 protocols. Bull Cancer 1997 ; 84 : 31-4
18. Chauvergne J, Durand M, Hoerni B et al. La chimiothérapie d'induction dans les cancers du sein à haut risque. Résultats d'une étude thérapeutique prospective. Bull Cancer 1979 ; 66 : 9-16
19. MacGrogan G, Mauriac L, Durand M, Bonichon F, Trojani M, de Mascarel I et al. Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB 1, pS2 and GSTπ. Br J Cancer 1996 ; 74 : 1458-65
20. Abraham DC, Jones C, Jones SE, Cheek JH, Peters GN, Knox SM et al. Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging. Cancer 1996 ; 78 : 91-100
21. Junkermann H, von Fournier D. Imaging methods for evaluating the response of breast carcinoma to preoperative chemotherapy. Radiology 1997 ; 37 : 726-32
22. Kling KM, Ostrzega N, Schmidt P. Breast conservation after induction chemotherapy for locally advanced breast cancer. Am Surg 1997 ; 63 : 861-4
23. Merajver SD, Weber BL, Cody R, Zhang D, Strawderman M, Calzone KA et al. Breast conservation and prolonged chemotherapy for locally advanced breast cancer: the university of Michigan experience. J Clin Oncol 1997 ; 15 : 2873-81
24. Heys SD, Eremin JM, Sarkar TK, Hutcheon AW, Ah-See A, Eremin O. Role of multimodality therapy in the management of locally advanced carcinoma of the breast. J Am Coll Surg 1994 ; 179 : 493-504
25. Hortobagyi GN, Ames FC, Buzdar AU, Kau SW, McNeese MD, Paulus D et al. Management of stage III primary breast cancer with primary chemotherapy, surgery and radiation therapy. Cancer 1988 ; 62 : 2507-16
26. Recht A. Preoperative chemotherapy and breast-conserving therapy, why not everyone? J Clin Oncol 1997 ; 15 : 2479-82
27. Salvadori B. Local recurrences after breast-conserving treatment: an open problem. Semin Surg Oncol 1996 ; 12 : 46-52
28. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F et al. Postoperative radiotherapy in high-risk pre-menopausal women with breast cancer who receive adjuvant chemotherapy Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997 ; 337 : 949-55